Cancel
Known information
- Is a Professor of Neurosciences and Biological Engineering at the Tianqiao and Chrissy Chen Institute of Neuroscience at Caltech
- Holds a Ph.D. in neuroscience
- Continues her involvement with Capsida as a member of the company's Board of Directors
About Capsida
Capsida develops targeted, non-invasive intravenous gene therapies for rare and common diseases, with a focus on CNS and ophthalmology disorders.
Report inaccurate information
